0001209191-18-022186.txt : 20180330
0001209191-18-022186.hdr.sgml : 20180330
20180330141452
ACCESSION NUMBER: 0001209191-18-022186
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180329
FILED AS OF DATE: 20180330
DATE AS OF CHANGE: 20180330
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOLD DANIEL P PHD
CENTRAL INDEX KEY: 0001288233
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50484
FILM NUMBER: 18725739
MAIL ADDRESS:
STREET 1: 10445 PACIFIC CENTER CT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MEI Pharma, Inc.
CENTRAL INDEX KEY: 0001262104
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 510407811
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 3611 VALLEY CENTER DRIVE
STREET 2: SUITE 500
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-792-6300
MAIL ADDRESS:
STREET 1: 3611 VALLEY CENTER DRIVE
STREET 2: SUITE 500
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: MARSHALL EDWARDS INC
DATE OF NAME CHANGE: 20030902
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-03-29
0
0001262104
MEI Pharma, Inc.
MEIP
0001288233
GOLD DANIEL P PHD
C/O MEI PHARMA, INC.
3611 VALLEY CENTRE DRIVE, SUITE 500
SAN DIEGO
CA
92130
1
1
0
0
Chief Executive Officer
Common Stock
2018-03-29
4
F
0
128920
2.07
D
271080
D
Represents the number of shares withheld by and surrendered to the Issuer on March 29, 2018, to satisfy tax withholding obligations that arose in connection with the delivery of shares underlying vested restricted stock units.
/s/ Brian G. Drazba, as attorney-in-fact
2018-03-30